Login  /  Register  | 3 premium articles left before you must register.

HomeBusinessPharmaceuticals News

Latest Stories

Premium Content Thomson Reuters exec joins Pfizer board

 July 2, 2014

Pfizer Inc. has a new member of its board of directors: James C. Smith, president and chief executive of Thomson Reuters. The 54-year-old has been appointed to the Corporate Governance and Science and Technology committees of Pfizer's...

 (1)

Premium Content Pfizer facility in Groton evacuated over concerns of bulging containers

 June 19, 2014

Groton – A Pfizer facility off Eastern Point Road was evacuated on Thursday following a report that two containers inside the building had built up pressure.

 (3)

Premium Content Pfizer opens R&D hub in Cambridge, Mass.

 June 17, 2014

Pfizer Inc. opened its new research-and-development hub at Kendall Square in Cambridge, Mass., on Monday.

 (0)

Premium Content Bioscience group elects Mackenzie

 June 14, 2014

Rod MacKenzie, site leader at Pfizer Inc.'s Groton campus, was elected last week to the board of the bioscience network Connecticut United for Research Excellence.

 (0)

Premium Content Event aims to help entrepreneurs connect

 June 8, 2014

PowerMatch isn’t a dating service; it’s a new way of business networking held late last month in new London, where 14 entrepreneurs met to find out more about others in the region.

 (0)

Premium Content Brazilian interns learning at Pfizer

 June 5, 2014

Twenty-three Brazilian interns will be working at Pfizer Inc. campuses across the country, including in Groton, as part of a program to introduce them to working scientists.

Undergraduate students will spend eight to 12 weeks working next...

 (1)

FDA approves generic versions of Pfizer's painkiller Celebrex

 May 31, 2014

The Food and Drug Administration on Friday approved the first generic versions of Pfizer's anti-inflammatory painkiller Celebrex.

 (3)

Premium Content Groton could use $900,000 from reserve to lower tax rate

 May 28, 2014

The tax rate in Groton would fall from 20.72 mills to 20.13 mills if a decision made Tuesday night is approved next week.

 (4)

Premium Content Courtney: Pfizer bid highlights the need for tax reform

 May 24, 2014

Mystic - U.S. Rep. Joe Courtney said Friday that Pfizer Inc.'s proposed acquisition of rival AstraZeneca partly to take advantage of more favorable tax laws overseas has reopened the debate in Congress about federal tax...

 (4)

Premium Content Courtney says tax reform needed

 May 23, 2014

U.S. Rep. Joe Courtney said today that pharmaceutical giant Pfizer Inc.’s proposed acquisition of rival AstraZeneca largely to take advantage of more favorable tax laws overseas has reopened the debate in Congress about tax reform.

 (10)

AstraZeneca board rejects new offer from Pfizer

 May 19, 2014

The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the...

 (4)

Premium Content Drug-resistant bacteria a growing concern

 May 16, 2014

Drug-resistant bacteria have become a "near critical situation," according to a St. Louis College of Pharmacy expert interviewed by reporter Mark Koba on CNBC.

Ryan Moenster, associate professor of pharmacy practice at the college, said the...

 (0)

Pfizer underscores UK commitments in memo

 May 12, 2014

Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of AstraZeneca, insisting that its promises will be legally binding.

 (1)

Columnists

No recent columns.

Interact

Most Recent Poll

No current items found